Literature DB >> 22993615

High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma.

Cheng-Huang Shen1, Hsiao-Yen Hsieh, Yuan-Hung Wang, Syue-Yi Chen, Chun-Liang Tung, Jiann-DER Wu, Chang-Te Lin, Michael W-Y Chan, Cheng-DA Hsu, Deching Chang.   

Abstract

Although Dickkopf-1 (DKK1) has been demonstrated to be associated with tumorigenesis in various types of human tumors, a correlation between DKK1 and urothelial carcinoma (UC) has not been reported. In the present study, the correlation between DKK1 expression and UC progression was investigated. Seventy-five UC patients were enrolled. The expression of DKK1 in serum and UC tissue was detected by ELISA, real-time PCR and Western blotting. Prognostic significance was assessed by using Kaplan-Meier survival estimates and log-rank tests. The results showed that serum levels of DKK1 were significantly higher in the UC patients with muscle-invasive (p=0.0001) and high-grade tumors (p=0.00001) as compared to the controls. A high-serum DKK1 was also associated with poor disease-free survival in the UC patients (hazard ratio=2.44; 95% CI 1.10-5.40; p=0.028). Furthermore, DKK1 was also overexpressed in 93% (41/44) of the UC tissues. Therefore, the findings indicate that the expression of DKK1 is associated with UC progression.

Entities:  

Year:  2010        PMID: 22993615      PMCID: PMC3445958          DOI: 10.3892/etm.2010.134

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  32 in total

1.  American Urological Association issues guidelines on the management of bladder cancer.

Authors:  S S Morey
Journal:  Am Fam Physician       Date:  2000-06-15       Impact factor: 3.292

Review 2.  Bladder cancer: epidemiology, diagnosis, and management.

Authors:  Chris Leo Pashos; Marc F Botteman; Benjamin Lewis Laskin; Alberto Redaelli
Journal:  Cancer Pract       Date:  2002 Nov-Dec

3.  Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.

Authors:  Takefumi Kikuchi; Yataro Daigo; Toyomasa Katagiri; Tatsuhiko Tsunoda; Koichi Okada; Soji Kakiuchi; Hitoshi Zembutsu; Yoichi Furukawa; Masafumi Kawamura; Koichi Kobayashi; Kohzoh Imai; Yusuke Nakamura
Journal:  Oncogene       Date:  2003-04-10       Impact factor: 9.867

4.  Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Authors:  Shinji Urakami; Hiroaki Shiina; Hideki Enokida; Toshifumi Kawakami; Takashi Tokizane; Tatsuya Ogishima; Yuichiro Tanaka; Long-Cheng Li; Leopoldo A Ribeiro-Filho; Masaharu Terashima; Nobuyuki Kikuno; Hiroyuki Adachi; Tatsuaki Yoneda; Hirofumi Kishi; Kazushi Shigeno; Badrinath R Konety; Mikio Igawa; Rajvir Dahiya
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

5.  Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.

Authors:  Masaya Taniwaki; Yataro Daigo; Nobuhisa Ishikawa; Atsushi Takano; Tatsuhiko Tsunoda; Wataru Yasui; Kouki Inai; Nobuoki Kohno; Yusuke Nakamura
Journal:  Int J Oncol       Date:  2006-09       Impact factor: 5.650

6.  Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Authors:  Carmen J Marsit; Margaret R Karagas; Angeline Andrew; Mei Liu; Hadi Danaee; Alan R Schned; Heather H Nelson; Karl T Kelsey
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

7.  Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.

Authors:  Cheng-Huang Shen; Yuan-Hung Wang; Wen-Chuang Wang; Yeong-Chin Jou; Hueih-Shing Hsu; Hsiao-Yen Hsieh; Hung-Yi Chiou
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

8.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

Review 9.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

10.  Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication.

Authors:  Efstathios Kastritis; Samuel Murray; Fani Kyriakou; Maria Horti; Nicolaos Tamvakis; Nicolaos Kavantzas; Efstratios S Patsouris; Aphrodite Noni; Sofia Legaki; Meletios A Dimopoulos; Aristotle Bamias
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

View more
  4 in total

1.  Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis.

Authors:  Yanqiong Liu; Weizhong Tang; Li Xie; Jian Wang; Yan Deng; Qiliu Peng; Limin Zhai; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-11-21

Review 2.  Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Authors:  Michael H Kagey; Xi He
Journal:  Br J Pharmacol       Date:  2017-07-07       Impact factor: 8.739

Review 3.  Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?

Authors:  Mélody Mazon; Delphine Masi; Madeleine Carreau
Journal:  Cancers (Basel)       Date:  2016-06-28       Impact factor: 6.639

4.  Prognostic role of dickkopf-1 in patients with cancer.

Authors:  Junfang Huang; Tao Lu; Wenbing Kuang
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.